Resources
-
Product Characterization and Role of Your Potency Assays
Roundtable Notes: Session 2 Table 4 Bioassays 2026
Product Characterization and Role of Your Potency Assays -
Platform Methods: Practical Considerations for the Implementation of Updated ICH Q14, ICH Q2, and USP <1220> [Session 2]
Roundtable Notes: Session 2 Table 2 Bioassays 2026
Platform Methods: Practical Considerations for the Implementation of Updated ICH Q14, ICH Q2, and USP <1220> -
Platform Methods: Practical Considerations for the Implementation of Updated ICH Q14, ICH Q2, and USP <1220>
Roundtable Notes: Session 1 Table 2 Bioassays 2026
Platform Methods: Practical Considerations for the Implementation of Updated ICH Q14, ICH Q2, and USP <1220> -
Method Comparability Considerations [Session 2]
Roundtable Notes: Session 2 Table 1 Bioassays 2026
Method Comparability Considerations -
Method Comparability Considerations
Roundtable Notes: Session 1 Table 1 Bioassays 2026
Method Comparability Considerations -
Learnings From Bioassay Transfers [Session 2]
Roundtable Notes: Session 2 Table 3 Bioassays 2026
Learnings From Bioassay Transfers -
Learnings From Bioassay Transfers
Roundtable Notes: Session 1 Table 3 Bioassays 2026
Learnings From Bioassay Transfers -
How Can We Enable Career Development for Young Scientists?
Roundtable Notes: Session 2 Table 6 Bioassays 2026
How Can We Enable Career Development for Young Scientists? -
Brainstorming on Applications of AI [Session 2]
Roundtable Notes: Session 2 Table 5 Bioassays 2026
Brainstorming on Applications of AI -
Brainstorming on Applications of AI
Roundtable Notes: Session 1 Table 5 Bioassays 2026
Brainstorming on Applications of AI -
Svar Life Science Vendor Showcase
Speaker Presentation: Bioassays 2026
Vendor Showcase, Svar Life Science, 2026 -
Stegmann Systems Vendor Showcase
Speaker Presentation: Bioassays 2026
Vendor Showcase, Stegmann Systems GmBH, 2026 -
Promega Vendor Showcase
Speaker Presentation: Bioassays 2026
Vendor Showcase, Promega Corporation, 2026 -
Custom Biologics Vendor Showcase
Speaker Presentation: Bioassays 2026
Vendor Showcase, Custom Biologics, 2026 -
Charles River Vendor Showcase
Speaker Presentation: Bioassays 2026
Vendor Showcase, Charles River, 2026 -
Accellerate Vendor Showcase
Speaker Presentation: Bioassays 2026
Vendor Showcase, acCELLerate, 2026 -
Catalent Vendor Showcase
Speaker Presentation: Bioassays 2026
Vendor Showcase, Catalent, 2026 -
Designing Robust
Cell-Based Potency Assays:
Strategic Frameworks and
Emerging Biological Readouts
Speaker Presentation: Bioassays 2026
Technical Seminar, Catalent, 2026 -
CMC Regulatory Considerations for Antibody-Drug Conjugates (ADCs) – From the Biologics Perspective
Speaker Presentation: Bioassays 2026
Zhang Lei, CDER, FDA, 2026 -
Hindsight is 20/20: 50 Years of Combined Bioassay Experiences
Speaker Presentation: Bioassays 2026
Ritter Nadine, Fuchs Chana, 2026